Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 19Other neoplasm 2Sarcoma 1Myeloid 1Dermatologic 1

Conditions

Precancerous Conditions 145Lymphoma 34Leukemia 32Multiple Myeloma 31Neoplasms, Plasma Cell 30Monoclonal Gammopathy of Undetermined Significance 30Lymphoma, Non-Hodgkin 29Lymphoma, Mantle-Cell 29Lymphoma, Large-Cell, Immunoblastic 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 29Leukemia, Lymphocytic, Chronic, B-Cell 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 28Burkitt Lymphoma 28Immunoglobulin Light-chain Amyloidosis 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26Hodgkin Disease 26Waldenstrom Macroglobulinemia 25Myeloproliferative Disorders 25Immunoblastic Lymphadenopathy 25Myelodysplastic Syndromes 24Lymphoma, Large-Cell, Anaplastic 24Leukemia, Hairy Cell 24Thrombocythemia, Essential 23Primary Myelofibrosis 23Leukemia, Myeloid, Acute 23Leukemia, Large Granular Lymphocytic 23Lymphoma, T-Cell, Cutaneous 22Leukemia, Prolymphocytic 22

Interventions

pirfenidone 1Vinblastine 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neurofibroma, Plexiform × Other neoplasm × Clear all
NCT00030264 2018-08-08

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Children's Hospital of Philadelphia

Phase 2 Completed
23 enrolled 9 charts
CNSOther neoplasm

Neurofibromatosis 1, Precancerous Conditions, Neurofibroma, Plexiform

NCT00053937 2015-04-30

Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas

National Cancer Institute (NCI)

Phase 1 Completed
CNSOther neoplasm

Neurofibromatosis 1, Precancerous Conditions, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡